Takeda Pharmaceutical Co.’s global oncology business unit, headquartered in Cambridge, MA, is now called Takeda Oncology. Takeda will sustain its approach to oncology R&D while expanding its global commercial network and resources as Takeda Oncology. Takeda is retiring the Millennium brand, replacing it with Takeda Oncology to reflect the new global oncology business unit.   Comprised of Takeda’s global oncology commercial operations, the Oncology Business Unit remains aligned with Takeda’s ...